Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 09

607P - Prognostic and reproductive assessment of omentectomy for patients with clinically apparent early-stage (I, II) malignant ovarian germ cell tumuors: A multicenter and retrospective study

Date

10 Sep 2022

Session

Poster session 09

Topics

Clinical Research;  Cancer and Pregnancy;  Surgical Oncology

Tumour Site

Ovarian Cancer

Presenters

Kun Song

Citation

Annals of Oncology (2022) 33 (suppl_7): S235-S282. 10.1016/annonc/annonc1054

Authors

K. Song, P. Liu, Z. Li

Author affiliations

  • Department Of Obstetrics And Gynecology, Qilu Hospital of Shandong University, 250012 - Jinan/CN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 607P

Background

To assess the impact of omentectomy on the prognosis and fertility outcomes of patients with clinically apparent early-stage (I, II) malignant ovarian germ cell tumors (MOGCT).

Methods

In this retrospective cohort analysis, 268 patients with clinically apparent early-stage (I, II) MOGCT between 2005 to 2020 from major university-teaching hospitals in China were identified. A 1:1 propensity score matching (PSM) between omentectomy and no-omentectomy groups was performed and disease-free survival (DFS), overall survival (OS) and reproductive outcomes were compared between groups.

Results

A total of 268 patients with clinically apparent early-stage MOGCT were included. And 187 (69.8%) patients underwent omentectomy, among whom 3 (1.6%) had omental metastasis. Kaplan-Meier analysis showed no significant differences in DFS and OS between omentectomy and no-omentectomy groups in the before and after PSM cohorts (p>0.05). Additionally, the subgroup analysis stratified by age <18 or ≥18 years, showed the similar results. Cox regression analysis revealed that the FIGO stage was the only risk factor associated with DFS (HR=14.71, CI 4.47-48.38, p<0.001) and OS (HR=37.36, CI 3.87-361.16, p=0.002). Regarding the fertility outcomes, the pregnancy rates and live birth rates of the total population were 80.3% and 66.7%, respectively. And there were no significant differences between the two groups in the before and after PSM cohorts.

Conclusions

Omentectomy did not seem to improve survival for either children/adolescent or adult patients with clinically apparent early-stage (I, II) MOGCT and had no impact on fertility outcomes. The FIGO stage was the independent risk factor associated with recurrence and death.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

This study was supported by the National Key Technology Research and Development Program of China (2019YFC1005200 and 2019YFC1005204), the Taishan Scholar Youth Project of Shandong Province (tsqn201812130), and the Research Leader Studio of Jinan (2019GXRC049).

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.